Publications by authors named "Lars Devisscher"

Claim this Profile
D
Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy.
Lars Devisscher, Samya Van Coillie, Sam Hofmans, Dries Van Rompaey, Kenneth Goossens

J Med Chem· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis.
Isabelle Coornaert, Sam Hofmans, Lars Devisscher, Koen Augustyns, Pieter Van Der Veken

Expert Opin Drug Discov· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tozasertib Analogues as Inhibitors of Necroptotic Cell Death.
Sam Hofmans, Lars Devisscher, Sofie Martens, Dries Van Rompaey, Kenneth Goossens

J Med Chem· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680).
Sofie Martens, Vera Goossens, Lars Devisscher, Sam Hofmans, Polien Claeys

Cell Death Dis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Ferroptosis Inhibitors with Improved Potency and ADME Properties.
Sam Hofmans, Tom Vanden Berghe, Lars Devisscher, Behrouz Hassannia, Sophie Lyssens

J Med Chem· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis